Related Experiment Video
Updated: May 12, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
The thrombophilic network of autoantibodies in celiac disease
Aaron Lerner1, Nancy Agmon-Levin, Yinon Shapira
1Pediatric Gastroenterology and Nutrition Unit, Carmel Medical Center, B, Rappaport School of Medicine, Technion-Israel institute of Technology, Michal St, No 7, Haifa, 34362, Israel. lerner_aaron@clalit.org.il
Insights
Celiac disease patients show higher levels of antiphosphatidylserine/prothrombin and antiprothrombin antibodies, suggesting these may contribute to thrombophilia. This finding could inform new anticoagulant therapies for celiac disease.
Area of Science:
- Immunology
- Gastroenterology
- Hematology
Background:
- Celiac disease is an autoimmune disorder linked to genetic susceptibility and thromboembolic events.
- Thrombophilia in celiac disease involves factors like hyperhomocysteinemia and vitamin deficiencies.
- Antiphosphatidylserine/prothrombin and antiprothrombin antibodies have not been previously studied in celiac disease.
Purpose of the Study:
- To investigate the presence and levels of antiphosphatidylserine/prothrombin and antiprothrombin antibodies in individuals with celiac disease.
- To compare autoantibody levels in celiac disease patients with healthy children and their family members.
Main Methods:
- Serum autoantibody levels were measured using enzyme-linked immunosorbent assay (ELISA) in 248 participants.
- Participants were divided into three groups: children with celiac disease (n=70), healthy children (n=88), and adult family members (n=90).
Main Results:
- Individuals with celiac disease exhibited significantly higher levels of antiphosphatidylserine/prothrombin IgG antibodies compared to controls (P <0.0001).
- Elevated antiprothrombin immunoglobulin G levels were observed in celiac disease patients and their family members compared to healthy children (P <0.005).
- A higher percentage of celiac disease patients were positive for antiphosphatidylserine/prothrombin antibodies (45.7%) versus controls (0%).
Conclusions:
- Increased autoantibodies, including antiphosphatidylserine/prothrombin and antiprothrombin, are associated with celiac disease.
- These autoantibodies may play a role in the thrombophilia observed in celiac disease.
- The identified autoantibodies could serve as potential markers for developing preventive anticoagulant therapies.
Background:
Celiac disease is a life-long autoimmune condition, affecting genetically susceptible individuals that may present with thromboembolic phenomena. This thrombophilia represents a puzzle with multiple constituents: hyperhomocysteinemia, B12 and\or folate deficiency, methylenetetrahydrofolate reductase mutations, and protein C and S deficiency due to vitamin K deficiency. However, the well known thrombogenic factors, antiphosphatidylserine/prothrombin and antiprothrombin have never been explored in celiac disease.
Methods:
The serum autoantibody levels were determined in 248 individuals, classified into three groups. Group 1 comprised 70 children with definitive celiac disease (age: 7.04 ±4.3 years, male to female ratio 1.06) and group 2 comprised 88 normal children (age: 6.7 ±4.17 years, male to female ratio 0.87), representing controls. The pediatric populations were compared to group 3, which included 90 adults who were family members (parents) of group 1 (age: 34.6 ±11.35 years, male to female ratio 1.2). Antibodies were checked by enzyme-linked immunosorbent assay.
Results:
Mean optical density levels of serum antiphosphatidylserine/prothrombin immunoglobulin G antibodies were 32.4 ±19.4, 3.6 ±2.5 and 16.1 ±15.8 absorbance units in groups 1, 2 and 3 respectively (P <0.0001), with 45.7%, 0% and 7.8% of groups 1, 2 and 3 respectively positive for the antibody (P <0.01). Mean optical density levels of serum antiphosphatidylserine/prothrombin immunoglobulin M antibodies were 14.2 ±8.7, 6.7 ±6.4 and 12.4 ±15.5 absorbance units in groups 1, 2 and 3 respectively (P <0.0001), with 7.1%, 3.4% and 9.9% of groups 1, 2 and 3 positive for the antibody. Mean optical density levels of serum antiprothrombin and antiphospholipid immunoglobulin G antibodies were higher in groups 1 and 3 compared with 2 (P <0.005) and in groups 1 and 2 compared with 3 (P <0.01), respectively. Groups 1, 2 and 3 were positive for antiphospholipid immunoglobulin G antibodies (groups 1 and 2 compared with 3) . Celiac disease sera harbor a higher antiprothrombin immunoglobulin G level compared with controls.
Conclusions:
It is suggested that the intestinal injury, endothelial dysfunction, platelet abnormality and enhanced apoptosis recently described in celiac disease are at the origin of the increased exposure of phospholipids or new epitopes representing autoantigens. Those autoantibodies might play a pathogenic role in the thrombophilia associated with celiac disease and represent markers for potential anticoagulant preventive therapy.
More Related Videos
Related Concept Videos
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Inflammatory Bowel Disease III: Crohn's Disease
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Graves' Disease I: Introduction
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...

